These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 15713481)

  • 1. Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2.
    Juárez-González VR; Riaño-Umbarila L; Quintero-Hernández V; Olamendi-Portugal T; Ortiz-León M; Ortíz E; Possani LD; Becerril B
    J Mol Biol; 2005 Mar; 346(5):1287-97. PubMed ID: 15713481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A strategy for the generation of specific human antibodies by directed evolution and phage display. An example of a single-chain antibody fragment that neutralizes a major component of scorpion venom.
    Riaño-Umbarila L; Juárez-González VR; Olamendi-Portugal T; Ortíz-León M; Possani LD; Becerril B
    FEBS J; 2005 May; 272(10):2591-601. PubMed ID: 15885107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel human recombinant antibody fragment capable of neutralizing Mexican scorpion toxins.
    Riaño-Umbarila L; Olamendi-Portugal T; Morelos-Juárez C; Gurrola GB; Possani LD; Becerril B
    Toxicon; 2013 Dec; 76():370-6. PubMed ID: 24067940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial expression, purification and functional characterization of a recombinant chimeric Fab derived from murine mAb BCF2 that neutralizes the venom of the scorpion Centruroides noxius hoffmann.
    Selisko B; Cosío G; García C; Becerril B; Possani LD; Horjales E
    Toxicon; 2004 Jan; 43(1):43-51. PubMed ID: 15037028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The change of the scFv into the Fab format improves the stability and in vivo toxin neutralization capacity of recombinant antibodies.
    Quintero-Hernández V; Juárez-González VR; Ortíz-León M; Sánchez R; Possani LD; Becerril B
    Mol Immunol; 2007 Feb; 44(6):1307-15. PubMed ID: 16814388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of three different formats of a neutralizing single chain human antibody against toxin Cn2: neutralization capacity versus thermodynamic stability.
    Quintero-Hernández V; Del Pozo-Yauner L; Pedraza-Escalona M; Juárez-González VR; Alcántara-Recillas I; Possani LD; Becerril B
    Immunol Lett; 2012 Apr; 143(2):152-60. PubMed ID: 22306104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody BCF2 against scorpion toxin Cn2 from Centuroides noxius Hoffmann: primary structure and three-dimensional model as free Fv fragment and complexed with its antigen.
    Selisko B; Licea AF; Becerril B; Zamudio F; Possani LD; Horjales E
    Proteins; 1999 Oct; 37(1):130-43. PubMed ID: 10451557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single mutation in framework 2 of the heavy variable domain improves the properties of a diabody and a related single-chain antibody.
    Rodríguez-Rodríguez ER; Ledezma-Candanoza LM; Contreras-Ferrat LG; Olamendi-Portugal T; Possani LD; Becerril B; Riaño-Umbarila L
    J Mol Biol; 2012 Oct; 423(3):337-50. PubMed ID: 22835504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of an epitope recognized by a neutralizing monoclonal antibody specific to toxin Cn2 from the scorpion Centruroides noxius, using discontinuous synthetic peptides.
    Calderon-Aranda ES; Selisko B; York EJ; Gurrola GB; Stewart JM; Possani LD
    Eur J Biochem; 1999 Sep; 264(3):746-55. PubMed ID: 10491120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity.
    Thompson J; Pope T; Tung JS; Chan C; Hollis G; Mark G; Johnson KS
    J Mol Biol; 1996 Feb; 256(1):77-88. PubMed ID: 8609615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fab fragments of the monoclonal antibody BCF2 are capable of neutralizing the whole soluble venom from the scorpion Centruroides noxius Hoffmann.
    Licea AF; Becerril B; Possani LD
    Toxicon; 1996 Aug; 34(8):843-7. PubMed ID: 8875771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display.
    Kobayashi N; Kato Y; Oyama H; Taga S; Niwa T; Sun P; Ohtoyo M; Goto J
    Steroids; 2008 Dec; 73(14):1485-99. PubMed ID: 18824188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of neutralizing single-chain antibodies against Xenopus mitogen-activated protein kinase kinase from phage display libraries.
    Kosako H; Akamatsu Y; Tsurushita N; Lee KK; Gotoh Y; Nishida E
    Biochemistry; 1996 Oct; 35(40):13212-21. PubMed ID: 8855960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The venom of the scorpion Centruroides limpidus, which causes the highest number of stings in Mexico, is neutralized by two recombinant antibody fragments.
    Fernández-Taboada G; Riaño-Umbarila L; Olvera-Rodríguez A; Gómez-Ramírez IV; Losoya-Uribe LF; Becerril B
    Mol Immunol; 2021 Sep; 137():247-255. PubMed ID: 34298407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering of a recombinant Fab from a neutralizing IgG directed against scorpion neurotoxin AahI, and functional evaluation versus other antibody fragments.
    Aubrey N; Muzard J; Christophe Peter J; Rochat H; Goyffon M; Devaux C; Billiald P
    Toxicon; 2004 Mar; 43(3):233-41. PubMed ID: 15033320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An nmr conformational analysis of a synthetic peptide Cn2(1-15)NH2-S-S-acetyl-Cn2(52-66)NH2 from the New World Centruroides noxius 2 (Cn2) scorpion toxin: comparison of the structure with those of the Centruroides scorpion toxins.
    Yamamoto H; Sejbal J; York E; Stewart JM; Possani LD; Kotovych G
    Biopolymers; 1999 Apr; 49(4):277-86. PubMed ID: 10079767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
    Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal Neutralization of Centruroides noxius Venom Is Understood through a Structural Complex between Two Antibody Fragments and the Cn2 Toxin.
    Riaño-Umbarila L; Ledezma-Candanoza LM; Serrano-Posada H; Fernández-Taboada G; Olamendi-Portugal T; Rojas-Trejo S; Gómez-Ramírez IV; Rudiño-Piñera E; Possani LD; Becerril B
    J Biol Chem; 2016 Jan; 291(4):1619-1630. PubMed ID: 26589800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An altered camelid-like single domain anti-idiotypic antibody fragment of HM-1 killer toxin: acts as an effective antifungal agent.
    Kabir ME; Krishnaswamy S; Miyamoto M; Furuichi Y; Komiyama T
    Appl Microbiol Biotechnol; 2011 Apr; 90(2):553-64. PubMed ID: 21305279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A.
    Razai A; Garcia-Rodriguez C; Lou J; Geren IN; Forsyth CM; Robles Y; Tsai R; Smith TJ; Smith LA; Siegel RW; Feldhaus M; Marks JD
    J Mol Biol; 2005 Aug; 351(1):158-69. PubMed ID: 16002090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.